<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Astellas Pharma Ltd from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Astellas Pharma Ltd news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 06:04:35 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Astellas+Pharma+Ltd" rel="self" type="application/rss+xml" />

	
<item><title>US pharma cos sue Lupin for patent infringement</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039676&amp;HITNO=0&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039676&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039676&amp;HITNO=0&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039676&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! India:</description></item>
<item><title>Daiichi Sankyo's subsidiary seeks approval for Alzheimer's type Dementia treatment in Japan</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039734&amp;HITNO=1&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039734&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538348937%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039734&amp;HITNO=1&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039734&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538348937%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038549&amp;HITNO=2&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038549&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537654652%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038549&amp;HITNO=2&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038549&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537654652%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Montana's News Station:</description></item>
<item><title>Astellas Pharma Inc.-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036411&amp;HITNO=3&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036411&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536604426%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036411&amp;HITNO=3&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036411&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536604426%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Ambit and Astellas Pharma: Working to release your inhibitors</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032819&amp;HITNO=4&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032819&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534826457%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032819&amp;HITNO=4&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032819&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534826457%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drug Discovery News:</description></item>
<item><title>XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038345&amp;HITNO=5&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038345&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537572442%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038345&amp;HITNO=5&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038345&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537572442%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038320&amp;HITNO=6&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038320&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537566409%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038320&amp;HITNO=6&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038320&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537566409%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>XenoPort Announces Extension of the Horizant(TM) PDUFA Date to Fe...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038129&amp;HITNO=7&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038129&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537492187%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038129&amp;HITNO=7&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038129&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537492187%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038097&amp;HITNO=8&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038097&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537472702%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038097&amp;HITNO=8&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038097&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537472702%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Centre Daily Times:</description></item>
<item><title>XenoPort Announces Extension of the Horizant&amp;#8222; PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038091&amp;HITNO=9&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038091&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537469973%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038091&amp;HITNO=9&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038091&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537469973%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038060&amp;HITNO=10&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038060&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537462802%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038060&amp;HITNO=10&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038060&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537462802%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038008&amp;HITNO=11&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038008&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537427250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038008&amp;HITNO=11&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038008&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537427250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037997&amp;HITNO=12&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037997&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537419311%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037997&amp;HITNO=12&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037997&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537419311%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037968&amp;HITNO=13&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037968&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537402212%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037968&amp;HITNO=13&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037968&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537402212%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037957&amp;HITNO=14&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037957&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537395020%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037957&amp;HITNO=14&amp;MSIZE=940&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Astellas%20Pharma%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037957&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537395020%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire:</description></item>
</channel></rss>